People · Operator

Wing Hung Wong

Named in public records as an officer, director or promoter · active 2011–2024 · Other Technology

2
Companies
3
Filings
$19.0M
Combined raised · real
Serial
Operator type
Companies
CompanyRoleSectorStageRaised · realValue · estTied
CyteSi, Inc.Other TechnologySeries A$12.4M$32.4M2022
BINA Technologies Inc.Other TechnologySeries A$6.6M$117.9M2011
Operator network

Wing Hung Wong at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.

Xi Chen · 4 companies · 1 sharedXi ChenTung-Yu Wu · 2 companies · 1 sharedTung-Yu WuPeng Hu · 1 companies · 1 sharedPeng HuBabak Yazdani · 18 companies · 1 sharedBabak YazdaniTim Guleri · 13 companies · 1 sharedTim GuleriFarzad Naimi · 5 companies · 1 sharedFarzad NaimiGarry Nolan · 2 companies · 1 sharedGarry NolanGarry P. Nolan · 2 companies · 1 sharedGarry P. NolanHarsh Patel · 2 companies · 1 sharedHarsh PatelRichard Murdock · 2 companies · 1 sharedRichard MurdockWing Wong · 2 companies · 1 sharedWing WongBabak Hung Yazdani · 1 companies · 1 sharedBabak Hung YazdaniFarzad Hung Naimi · 1 companies · 1 sharedFarzad Hung NaimiNarges Bani Asadi · 1 companies · 1 sharedNarges Bani AsadiCyteSi, Inc. · $12.4M raisedCyteSi, Inc.BINA Technologies Inc. · $6.6M raisedBINA Technologies Inc.Wing Hung WongWW
Wing Hung Wong Company Co-operator (ring = serial)Hover to isolate ties · click to open
Co-operators (shared boards)

People named alongside Wing Hung Wong on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.

OperatorSharedTheir companies
Babak Yazdani118
Tim Guleri113
Farzad Naimi15
Xi Chen14
Garry P. Nolan12
Richard Murdock12
Tung-Yu Wu12
Harsh Patel12
Garry Nolan12
Wing Wong12
Narges Bani Asadi11
Farzad Hung Naimi11
Peng Hu11
Babak Hung Yazdani11

People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.